BIOMEDICAL TECHNOLOGY

$0P30FY2002CANIH

University Of California Davis, Davis CA

Investigators

Linked publications & trials

Paper 39725713 Paper 39620216 Paper 39616300 Paper 39488208 Paper 39453739 Paper 39440945 Paper 39384967 Paper 39383000 Paper 39350111 Paper 39345479 Paper 39345391 Paper 39257973 Paper 39252929 Paper 39217266 Paper 39177582 Paper 39168154 Paper 39108503 Paper 39103353 Paper 39056190 Paper 39046599 Paper 39012466 Paper 38990223 Paper 38979288 Paper 38969563 Paper 38947002 Paper 38885336 Paper 38877132 Paper 38865710 Paper 38843382 Paper 38826195 Paper 38803393 Paper 38798575 Paper 38780011 Paper 38741109 Paper 38733599 Paper 38676662 Paper 38675754 Paper 38631708 Paper 38613431 Paper 38585965 Paper 38542325 Paper 38508788 Paper 38435525 Paper 38429100 Paper 38424319 Paper 38391921 Paper 38379924 Paper 38352523 Paper 38341356 Paper 38327800 Paper 38325550 Paper 38306117 Paper 38275528 Paper 38251655 Paper 38240593 Paper 38240588 Paper 38201656 Paper 38196111 Paper 38195324 Paper 38177179 Paper 38148295 Paper 38135713 Paper 38110836 Paper 38089570 Paper 38060241 Paper 38038862 Paper 38026426 Paper 37981238 Paper 37971282 Paper 37956278 Paper 37921263 Paper 37863103 Paper 37855863 Paper 37799388 Paper 37788324 Paper 37786690 Paper 37770015 Paper 37747056 Paper 37740742 Paper 37737264 Paper 37729195 Paper 37696458 Paper 37684434 Paper 37650871 Paper 37638022 Paper 37626712 Paper 37610042 Paper 37566056 Paper 37545516 Paper 37511154 Paper 37503036 Paper 37445930 Paper 37408799 Paper 37406471 Paper 37380074 Paper 37272771 Paper 37256599 Paper 37253267 Paper 37206147 Paper 37201177

Abstract

The Biomedical Technology Program of the Integrated Cancer Center is a cross-disciplinary (physical and life sciences and engineering) organization whose objectives are to create innovative devices and technology especially designed for the needs of the Center's researchers and clinicians. The program promotes multi-disciplinary research teams focused on revolutionary advances in methods and technology for cancer diagnosis and therapy. The program's thrusts are divided into two distinct R&D themes: 1) imaging/diagnostics and 2) therapeutic devices/technology. Specific projects include clinical trials to evaluate the differences between digital and film screen mammography, and the evaluation of high precision Monte Carlo computational techniques for calculating dose delivery to tumors during radiotherapy; design-driven research to develop new instrumentation for infra-red imaging and detection of bladder and colon cancers. An NCI Unconventional Innovations Program project will develop a compact and tunable narrow- bandwidth x-ray source for improving image contrast and resolution for mammography and improve the specificity of radioimmunotherapy techniques. The imaging/diagnostics themes, embodies a substantial effort focused on developing new technologies and methods for small animal metastasis and angiogenesis studies. The program contains a NCRR funded Accelerator Mass Spectrometry facility which provides the capability of performing assays with attomole sensitivity levels (6x10 molecules), for example to detect extremely small levels of tumor- specific growth proteins in the blood or to monitor therapeutic response to drugs or other interventions. The imaging and therapeutic themes of the Program are coordinated with and supportive of the themes within Cancer Biology (development of small animal imaging/detection technology), Cancer Therapeutics (drug metabolism, tumor response), and Prostate Cancer Programs (accurate radiotherapy dose delivery planning, new ultrasound technology for blood flow mapping and local pharmaceutical delivery.

View original record on NIH RePORTER →